Try our Advanced Search for more refined results

FDA Clears Sandoz Biosimilar Of Amgen's Enbrel

By Dani Kass (August 30, 2016, 9:06 PM EDT) -- The U.S. Food and Drug Administration on Tuesday approved Sandoz Inc.'s biosimilar for Amgen Inc.'s immunosuppressant Enbrel to treat certain types of arthritis and psoriasis, bringing the number of biosimilars the agency has approved to three....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!